Clinical Trial Update: Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating intravenous vitamin C in COVID-19 patients with hypoxia; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxia

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center | Conditions: COVID-19, Hypoxia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-02-24